Skip to main content
. 2018 Nov 21;2018(11):CD006135. doi: 10.1002/14651858.CD006135.pub3

Passeron 2006.

Methods Three‐month parallel‐group randomised controlled trial
Participants Forty‐eight children 2 to 12 years of age with moderate/severe eczema diagnosed by UK Working Party Criteria and total SCORAD over 14. Randomisation was done at a 1:1 ratio: 24 participants were randomised in each arm. Exclusion criteria included current flare of eczema, exposure to systemic corticosteroids or immunosuppressants in the previous 3 months, and other known immune deficiency
Setting: hospital dermatology clinic in France
Nine participants lost to follow‐up
Interventions Skim milk powder, potato starch, and lactose‐containing prebiotic, with or without Lactobacillus rhamnosus Lcr35 at 3.6 × 10⁹ CFUs/d, given as a 3‐times‐daily dose mixed with cold water or other liquid
Outcomes • Parent or participant global assessment of eczema severity*
 • SCORAD*
 • Investigator global assessment of eczema severity*
 Assessments were done at baseline and at 1, 2, and 3 months
*Denotes outcomes prespecified for this review
Notes Three episodes of mild abdominal pain reported ‐ 2 in probiotic group, 1 in placebo (prebiotic alone) group
Funding and conflict of interest not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated randomisation sequence as confirmed by study authors. Judged as having low risk of bias
Allocation concealment (selection bias) Low risk Adequate as confirmed by study authors and judged as having low risk
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Quote: "The patients, their parents and the dermatologists were blinded to the treatment the patient was receiving" ‐ "Each patient was examined by the same dermatologist at each visit"
Study authors confirmed blinding of all parties in the trial
Comment: probably done and judged as adequate for low risk of bias
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Quote: "The patients, their parents and the dermatologists were blinded to the treatment the patient was receiving" "Each patient was examined by the same dermatologist at each visit"
Study authors confirmed blinding of all parties in the trial
Comment: probably done and judged as adequate for low risk of bias
Incomplete outcome data (attrition bias) 
 All outcomes High risk Available case analysis used without exclusions after randomisation with low total rates of loss to follow‐up (18.7%). Losses to follow‐up per group: 29% in synbiotic group and 8% in placebo group. Reasons for losses in the synbiotic group were non‐attendance at follow‐up visits (5/24 participants) and withdrawal of consent (2/24). In the prebiotic group, 2/24 participants did not attend for follow‐up
Significant differences in rates of loss to follow‐up in the 2 groups, which probably had an impact on all outcomes
Selective reporting (reporting bias) Low risk No evidence of selective reporting
Other bias Unclear risk Funding and conflict of interest not reported